NDC 69336-831

NDC 69336-831

NDC 69336-831 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 69336-831
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 69336-831-30 [69336083130]

Vexasyn
Marketing Categorypremarket notification
Application NumberK020540
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-02
Marketing End Date2018-01-17

NDC 69336-831-01 [69336083101]

Vexasyn
Marketing Categorypremarket notification
Application NumberK020540
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2018-01-02
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.